WO2001026603A3 - Mesoprogestines (modulateurs de recepteur de progesterone) comme composants de contraceptifs feminins - Google Patents
Mesoprogestines (modulateurs de recepteur de progesterone) comme composants de contraceptifs feminins Download PDFInfo
- Publication number
- WO2001026603A3 WO2001026603A3 PCT/IB2000/002053 IB0002053W WO0126603A3 WO 2001026603 A3 WO2001026603 A3 WO 2001026603A3 IB 0002053 W IB0002053 W IB 0002053W WO 0126603 A3 WO0126603 A3 WO 0126603A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mesoprogestins
- female
- progesterone receptor
- component
- contraception
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA2002032429A UA77150C2 (en) | 1999-08-31 | 2000-08-31 | Use of mesoprogestins j867, j912, or j1042 for female contraception, pharmaceutical composition and kit (variants) |
MXPA02002186A MXPA02002186A (es) | 1999-08-31 | 2000-08-31 | Mesoprogestinas (moduladores del receptor de progesterona) como un componente de los anticonceptivos femeninos. |
EP00991299A EP1605949A2 (fr) | 1999-08-31 | 2000-08-31 | Mesoprogestines (modulateurs de recepteur de progesterone) comme composants de contraceptifs feminins |
AU32150/01A AU781835B2 (en) | 1999-08-31 | 2000-08-31 | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
KR1020027002785A KR20020038745A (ko) | 1999-08-31 | 2000-08-31 | 여성 피임제 성분으로서의 메조프로게스틴 (프로게스테론수용체 조절물질) |
HU0202515A HUP0202515A3 (en) | 1999-08-31 | 2000-08-31 | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
SK298-2002A SK2982002A3 (en) | 1999-08-31 | 2000-08-31 | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
BR0013711-1A BR0013711A (pt) | 1999-08-31 | 2000-08-31 | Mesoprogestinas (moduladores de receptores de progesterona) como um componente de contraceptivos femininos |
IL14841500A IL148415A0 (en) | 1999-08-31 | 2000-08-31 | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
PL00353994A PL353994A1 (en) | 1999-08-31 | 2000-08-31 | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
SI200020043A SI20853A (sl) | 1999-08-31 | 2000-08-31 | Mezoprogestini (modulatorji receptorja progesterona) kot sestavina ženskih kontraceptivov |
CA002383650A CA2383650A1 (fr) | 1999-08-31 | 2000-08-31 | Mesoprogestines (modulateurs de recepteur de progesterone) comme composants de contraceptifs feminins |
EA200200284A EA006805B1 (ru) | 1999-08-31 | 2000-08-31 | Мезопрогестины (модуляторы рецептора прогестерона) в качестве компонента женских контрацептивов |
EEP200200103A EE200200103A (et) | 1999-08-31 | 2000-08-31 | Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina |
NZ517470A NZ517470A (en) | 1999-08-31 | 2000-08-31 | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
JP2001529395A JP2003511399A (ja) | 1999-08-31 | 2000-08-31 | 女性避妊薬の成分としてのメソプロゲスチン(プロゲステロン受容体モジュレーター) |
BG06441A BG106441A (bg) | 1999-08-31 | 2002-02-26 | Мезопрогестини (модулатори на прогестероновия рецептор) като компоненти на женски контрацептиви |
NO20020998A NO20020998L (no) | 1999-08-31 | 2002-02-28 | Mesoprogestiner (progesteronreseptormodulater) som en komponent i svangerskapsforebyggelse for kvinner |
HR20020265A HRP20020265A2 (en) | 1999-08-31 | 2002-03-28 | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38613399A | 1999-08-31 | 1999-08-31 | |
US09/386,133 | 1999-08-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001026603A2 WO2001026603A2 (fr) | 2001-04-19 |
WO2001026603A3 true WO2001026603A3 (fr) | 2002-01-17 |
Family
ID=23524305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2000/002053 WO2001026603A2 (fr) | 1999-08-31 | 2000-08-31 | Mesoprogestines (modulateurs de recepteur de progesterone) comme composants de contraceptifs feminins |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP1605949A2 (fr) |
JP (1) | JP2003511399A (fr) |
KR (1) | KR20020038745A (fr) |
CN (1) | CN1384748A (fr) |
AR (1) | AR025455A1 (fr) |
AU (1) | AU781835B2 (fr) |
BG (1) | BG106441A (fr) |
BR (1) | BR0013711A (fr) |
CA (1) | CA2383650A1 (fr) |
CO (1) | CO5190694A1 (fr) |
CZ (1) | CZ2002707A3 (fr) |
EA (1) | EA006805B1 (fr) |
EE (1) | EE200200103A (fr) |
HR (1) | HRP20020265A2 (fr) |
HU (1) | HUP0202515A3 (fr) |
IL (1) | IL148415A0 (fr) |
LT (1) | LT5001B (fr) |
LV (1) | LV12940B (fr) |
MX (1) | MXPA02002186A (fr) |
NO (1) | NO20020998L (fr) |
NZ (1) | NZ517470A (fr) |
PE (1) | PE20010579A1 (fr) |
PL (1) | PL353994A1 (fr) |
SI (1) | SI20853A (fr) |
SK (1) | SK2982002A3 (fr) |
UA (1) | UA77150C2 (fr) |
WO (1) | WO2001026603A2 (fr) |
YU (1) | YU13902A (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
DK1525215T3 (da) * | 2002-08-02 | 2007-01-15 | Schering Ag | Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner |
US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
US20050215535A1 (en) * | 2004-03-24 | 2005-09-29 | Kristof Chwalisz | Sequential SPRM/progestin treatment |
EP1773344A1 (fr) * | 2004-07-07 | 2007-04-18 | Wyeth a Corporation of the State of Delaware | Schémas cycliques de progestérone et trousses d"administration |
DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
JP5951480B2 (ja) * | 2009-04-14 | 2016-07-13 | ラボラトワール・アシュエールア−ファルマLaboratoire Hra−Pharma | オンデマンド避妊方法 |
CN110548034A (zh) * | 2019-07-12 | 2019-12-10 | 广州莎蔓生物科技有限公司 | 一种怀孕阻断药物 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0309263A2 (fr) * | 1987-09-24 | 1989-03-29 | Jencap Research Limited | Composition d'hormones et application |
DE4332284A1 (de) * | 1993-09-20 | 1995-03-23 | Jenapharm Gmbh | Neue 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
WO1996012494A1 (fr) * | 1994-10-24 | 1996-05-02 | Schering Aktiengesellschaft | Antagonistes competitifs de la progesterone permettant de reguler a la demande la fecondite feminine |
WO1997041866A1 (fr) * | 1996-05-07 | 1997-11-13 | Schering Aktiengesellschaft | Augmentation du taux d'implantation apres fecondation in vitro |
US5693628A (en) * | 1993-09-20 | 1997-12-02 | Jenapharm Gmbh | 11-benzaldoxime-estra-diene derivatives, methods for their production and pharmaceuticals containing these compounds |
WO1997049407A1 (fr) * | 1996-06-25 | 1997-12-31 | Akzo Nobel N.V. | Schemas posologiques de progestogene et anti-progestogene |
WO1998005679A2 (fr) * | 1996-08-05 | 1998-02-12 | Duke University | Antagonistes mixtes du recepteur progesterone et techniques de dosage associees |
DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
WO2000066590A2 (fr) * | 1999-05-04 | 2000-11-09 | Ligand Pharmaceuticals, Inc. | Composes modulateurs de recepteur de progesterone tetracycliques et procedes |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2054271A (en) | 1932-05-17 | 1936-09-15 | Schering Kahlbaum Ag | Production of crystallized hormone esters |
DE699310C (de) | 1936-11-20 | 1940-11-27 | Chemische Ind Ges | Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols |
US2225419A (en) | 1937-03-01 | 1940-12-17 | Schering Corp | Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols |
US2611773A (en) | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
US2990414A (en) | 1957-03-26 | 1961-06-27 | Syntex Sa | 17-undecenoate of estradiol |
DE3337450A1 (de) | 1983-10-12 | 1985-04-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandine und antigestagene fuer den schwangerschaftsabbruch |
US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
US5516769A (en) | 1993-02-19 | 1996-05-14 | The Medical College Of Hampton Roads | Method of inhibiting fertilization |
DE4429397C2 (de) | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
DE4429398C2 (de) | 1994-08-09 | 1997-09-11 | Jenapharm Gmbh | Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption |
-
2000
- 2000-08-31 IL IL14841500A patent/IL148415A0/xx unknown
- 2000-08-31 AR ARP000104536A patent/AR025455A1/es unknown
- 2000-08-31 CO CO00065517A patent/CO5190694A1/es not_active Application Discontinuation
- 2000-08-31 CA CA002383650A patent/CA2383650A1/fr not_active Abandoned
- 2000-08-31 MX MXPA02002186A patent/MXPA02002186A/es not_active Application Discontinuation
- 2000-08-31 UA UA2002032429A patent/UA77150C2/uk unknown
- 2000-08-31 EA EA200200284A patent/EA006805B1/ru not_active IP Right Cessation
- 2000-08-31 KR KR1020027002785A patent/KR20020038745A/ko not_active Application Discontinuation
- 2000-08-31 JP JP2001529395A patent/JP2003511399A/ja active Pending
- 2000-08-31 WO PCT/IB2000/002053 patent/WO2001026603A2/fr not_active Application Discontinuation
- 2000-08-31 PE PE2000000894A patent/PE20010579A1/es not_active Application Discontinuation
- 2000-08-31 AU AU32150/01A patent/AU781835B2/en not_active Ceased
- 2000-08-31 PL PL00353994A patent/PL353994A1/xx not_active Application Discontinuation
- 2000-08-31 EE EEP200200103A patent/EE200200103A/xx unknown
- 2000-08-31 CZ CZ2002707A patent/CZ2002707A3/cs unknown
- 2000-08-31 CN CN00812308A patent/CN1384748A/zh active Pending
- 2000-08-31 HU HU0202515A patent/HUP0202515A3/hu unknown
- 2000-08-31 NZ NZ517470A patent/NZ517470A/en unknown
- 2000-08-31 YU YU13902A patent/YU13902A/sh unknown
- 2000-08-31 EP EP00991299A patent/EP1605949A2/fr not_active Withdrawn
- 2000-08-31 SK SK298-2002A patent/SK2982002A3/sk unknown
- 2000-08-31 SI SI200020043A patent/SI20853A/sl not_active IP Right Cessation
- 2000-08-31 BR BR0013711-1A patent/BR0013711A/pt not_active IP Right Cessation
-
2002
- 2002-02-26 BG BG06441A patent/BG106441A/bg unknown
- 2002-02-28 NO NO20020998A patent/NO20020998L/no not_active Application Discontinuation
- 2002-03-26 LT LT2002035A patent/LT5001B/lt not_active IP Right Cessation
- 2002-03-28 LV LVP-02-52A patent/LV12940B/en unknown
- 2002-03-28 HR HR20020265A patent/HRP20020265A2/hr not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0309263A2 (fr) * | 1987-09-24 | 1989-03-29 | Jencap Research Limited | Composition d'hormones et application |
DE4332284A1 (de) * | 1993-09-20 | 1995-03-23 | Jenapharm Gmbh | Neue 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US5693628A (en) * | 1993-09-20 | 1997-12-02 | Jenapharm Gmbh | 11-benzaldoxime-estra-diene derivatives, methods for their production and pharmaceuticals containing these compounds |
WO1996012494A1 (fr) * | 1994-10-24 | 1996-05-02 | Schering Aktiengesellschaft | Antagonistes competitifs de la progesterone permettant de reguler a la demande la fecondite feminine |
WO1997041866A1 (fr) * | 1996-05-07 | 1997-11-13 | Schering Aktiengesellschaft | Augmentation du taux d'implantation apres fecondation in vitro |
WO1997049407A1 (fr) * | 1996-06-25 | 1997-12-31 | Akzo Nobel N.V. | Schemas posologiques de progestogene et anti-progestogene |
WO1998005679A2 (fr) * | 1996-08-05 | 1998-02-12 | Duke University | Antagonistes mixtes du recepteur progesterone et techniques de dosage associees |
DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
WO2000066590A2 (fr) * | 1999-05-04 | 2000-11-09 | Ligand Pharmaceuticals, Inc. | Composes modulateurs de recepteur de progesterone tetracycliques et procedes |
Non-Patent Citations (3)
Title |
---|
CONRAD, CONRAD PROGRAM BIENNIAL REPORT 1998-1999, XP002170202, Retrieved from the Internet <URL:http://www.conrad.org/bi-annual_Report.pdf> [retrieved on 20010620] * |
JEWGENOW K ET AL: "Comparative binding affinity study of progestins to the cytosol progestin receptor of endometrium in different mammals.", GENERAL AND COMPARATIVE ENDOCRINOLOGY, vol. 110, no. 2, May 1998 (1998-05-01), pages 118 - 124, XP001006069, ISSN: 0016-6480 * |
QUEST M ET AL: "Antigestagens - a new contraceptive method in captive bears?", REPRODUCTION IN DOMESTIC ANIMALS, vol. 34, no. 1, February 1999 (1999-02-01), 32nd Conference on Physiology and Pathology of Reproduction;Hannover, Germany; February 18-19, 1999, pages 32, XP001006070, ISSN: 0936-6768 * |
Also Published As
Publication number | Publication date |
---|---|
SI20853A (sl) | 2002-10-31 |
NO20020998D0 (no) | 2002-02-28 |
LT5001B (lt) | 2003-03-25 |
EA006805B1 (ru) | 2006-04-28 |
LV12940B (en) | 2003-06-20 |
BG106441A (bg) | 2002-09-30 |
KR20020038745A (ko) | 2002-05-23 |
MXPA02002186A (es) | 2002-09-02 |
CZ2002707A3 (cs) | 2002-11-13 |
CN1384748A (zh) | 2002-12-11 |
YU13902A (sh) | 2006-01-16 |
PE20010579A1 (es) | 2001-06-04 |
CO5190694A1 (es) | 2002-08-29 |
JP2003511399A (ja) | 2003-03-25 |
SK2982002A3 (en) | 2002-07-02 |
PL353994A1 (en) | 2003-12-15 |
WO2001026603A2 (fr) | 2001-04-19 |
AR025455A1 (es) | 2002-11-27 |
EE200200103A (et) | 2003-04-15 |
LT2002035A (lt) | 2002-10-25 |
EP1605949A2 (fr) | 2005-12-21 |
HUP0202515A3 (en) | 2004-06-28 |
HRP20020265A2 (en) | 2004-02-29 |
CA2383650A1 (fr) | 2001-04-19 |
IL148415A0 (en) | 2002-09-12 |
NZ517470A (en) | 2004-03-26 |
HUP0202515A2 (hu) | 2002-12-28 |
EA200200284A1 (ru) | 2002-10-31 |
AU3215001A (en) | 2001-04-23 |
BR0013711A (pt) | 2002-05-07 |
NO20020998L (no) | 2002-03-14 |
UA77150C2 (en) | 2006-11-15 |
AU781835B2 (en) | 2005-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002352334A1 (en) | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof | |
WO2002047693A3 (fr) | Produits a base d'hormone steroide et leurs procedes de fabrication | |
TW200607798A (en) | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | |
WO2000066590A3 (fr) | Composes modulateurs de recepteur de progesterone tetracycliques et procedes | |
CA2188907A1 (fr) | Compose pour contraception basee sur les oestrogenes naturels | |
HUP0104718A3 (en) | Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions | |
HUP0104037A3 (en) | Drug delivery device, especially for the delivery of progestins and estrogens | |
WO1998025595A3 (fr) | Agents therapeutiques | |
BG101553A (en) | Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives | |
WO2004110408A3 (fr) | Formulation pharmaceutique pour la contraception et le traitement hormonal substitutif | |
WO2000012623A3 (fr) | Utilisation | |
WO2001026603A3 (fr) | Mesoprogestines (modulateurs de recepteur de progesterone) comme composants de contraceptifs feminins | |
WO2000074649A3 (fr) | Compositions ophtalmiques a base d'histamine et leurs utilisations | |
EP1090639A3 (fr) | Composition pharmaceutique contenant un corticoide progestatif et un modulateur sélectif du récepteur oestrogénique | |
AU9621598A (en) | Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive | |
WO2001015679A3 (fr) | Mesoprogestines (modulateurs du recepteur de la progesterone) pour le traitement et la prevention de troubles gynecologiques hormonodependants benins | |
WO2001034126A3 (fr) | Mesoprogestines (modulateurs des recepteurs de progesterone) utilises comme composants de compositions de traitement hormonal substitutif | |
WO2005058287A3 (fr) | Administration transdermique d'hormones sans utilisation d'un agent facilitant la penetration | |
WO2001028578A3 (fr) | Composition pharmaceutique a base de pglu-glu-pro-nh2 et procede de traitement de maladies et de lesions cerebrales | |
WO1996028154A3 (fr) | Utilisation d'anti-oestrogenes comme contraceptifs masculins | |
WO2000003678A3 (fr) | Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives | |
AU1901401A (en) | Condom set for preventing premature ejaculation | |
AU1167097A (en) | 18-methyl 16-methylene 19-nor pregnane derivatives as progestins, pharmaceutical compositions containing them and process for the preparation thereof | |
AU2002242980A1 (en) | Remedies for retina and choroid diseases containing steroids as the active ingredient | |
SI1219632T1 (sl) | Steroidi, njihova priprava, farmacevtski sestavki, ki jih vsebujejo, in uporabe spojin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: P-139/02 Country of ref document: YU |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200020043 Country of ref document: SI |
|
ENP | Entry into the national phase |
Ref document number: 2000 106441 Country of ref document: BG Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 517470 Country of ref document: NZ Ref document number: PV2002-707 Country of ref document: CZ Ref document number: 200201614 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 148415 Country of ref document: IL Ref document number: 2982002 Country of ref document: SK Ref document number: 2383650 Country of ref document: CA Ref document number: 32150/01 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2002 200200231 Country of ref document: RO Kind code of ref document: A Ref document number: 2001 529395 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027002785 Country of ref document: KR Ref document number: 00812308X Country of ref document: CN Ref document number: PA/A/2002/002186 Country of ref document: MX Ref document number: IN/PCT/2002/00247/DE Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200200284 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002035 Country of ref document: LT |
|
ENP | Entry into the national phase |
Ref document number: 2002 20020052 Country of ref document: LV Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20020265A Country of ref document: HR Ref document number: 200220020052 Country of ref document: LV |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000991299 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027002785 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002035 Country of ref document: LT |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-707 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002035 Country of ref document: LT |
|
WWP | Wipo information: published in national office |
Ref document number: 517470 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 517470 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 32150/01 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000991299 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000991299 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2002-707 Country of ref document: CZ |